Newest first. 5.2k questions across 107 tags.
The particulars: tirzepatide · 5 mg. I would rather understand the derivation than memorise the outcome. Two people I asked gave two answers that differ by a factor…
I keep a written log of every draw with date, volume and syringe type. I want to understand what this actually establishes, as opposed to what it is being used to…
The specifics, since they change the answer: 97.1% · ecnoglutide · SGN. I would like to define my thresholds before I have a result, for obvious reasons. I want a…
The particulars: 2 mg/mL · survodutide. The comparison I want does not seem to exist anywhere in a form I can evaluate. I have read the arguments for each and they do…
The particulars: deamidation · semaglutide · 37 °C. I would like the mechanism, because I want to be able to reason about the cases nobody has written about. I have…
The specifics, since they change the answer: AST · ALT · cagrilintide. The comparison I want does not seem to exist anywhere in a form I can evaluate. I have read the…
Setup, so nobody has to ask: retatrutide · eight weeks · 30 °C. I would like to set this up properly once, rather than adjust it repeatedly. My budget is real but not…
Stated plainly: hair thinning · eight · survodutide. This is a procedural question rather than a theoretical one, and I would like the procedure rather than the…
The vial was lyophilised at the time, which I understand may matter a great deal. I keep seeing this stated as a fact with no explanation attached, and unexplained…
Stated plainly: STEP 4 · injection-site erythema · 2.5 mg. I would like help reading this properly rather than being told what conclusion to reach. I have the full…
Stated plainly: orforglipron · 5 mg/mL. I have worked this out and I would like someone to find the error, because I suspect there is one. My working so far, for the…
The lot number on the vial matches the certificate, which at least rules out the easy problem. I keep seeing this stated as a fact with no explanation attached, and…
Setup, so nobody has to ask: 2–8 °C · cagrilintide. This is asserted often enough that I assumed it was established, and then I went looking for the source. I have…
What I am working with: WXT · identity confirmation by mass spectrometry. I have worked this out and I would like someone to find the error, because I suspect there…
What I am working with: WXT · GL Biochem (Shanghai). Both of these get recommended confidently by different people, which suggests neither is obviously right. My…
Setup, so nobody has to ask: LDL-C · a GLP-1 receptor agonist. I keep seeing this stated as a fact with no explanation attached, and unexplained facts make me…
What I am working with: 97.9% · a C18 column · ecnoglutide. I would like help reading this properly rather than being told what conclusion to reach. I have the full…
What I have: mazdutide · sixteen weeks · 4 °C. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can tell me which…
Details up front: a GLP-1 receptor agonist · a C8 column · semaglutide. I have used one of these for a while and I am considering switching, which requires a reason.…
Details up front: SELECT · nausea. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to disagree,…
I have three data points across nine months, which I hope is enough to see a trend. This is presented as though it settles something, and I am not convinced it does.…
What I have: a GLP-1 receptor agonist · 40 mg. I can do the algebra. I am not confident about the conversion factors. If there is a standard way to lay this out, I…
Details up front: Wuxi · Ireland. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to disagree,…
Numbers first: Wuxi · Singapore. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to disagree, which…